The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Measles would likely be the first eradicated disease to return, because it is so highly contagious, but other diseases like ...

Novavax announced that it's COVID-19 vaccine could get full approval from the U.S. Food and Drug Administration soon.The ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

Shares of Novavax Inc. NVAX shed 5.66% to $6.67 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.26% to 17,382.94 ...

Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

A new poll shows Trump's approval sinking as Americans brace for skyrocketing prices and recession fears fueled by his tariff ...

Market Domination host Julie Hyman takes a look at some of the top stories on April 25, 2025 as tariffs continue to be top of ...

The cable operator reported its first-quarter earnings ahead of Friday's opening bell. Chief executives are warning that big-ticket items will cost more, while travel becomes an early trade-war ...

James Willhite was an editor with The Wall Street Journal's money & investing team based in London.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.